iota Biosciences, a developer of implantable bioelectronic devices, expanded its leadership team following completion of its $15 million Series A funding round led by Horizons Ventures, Astellas, Bold Capital Partners, Ironfire, and Shanda. The company named James Hattersley as senior vice president of corporate business
Akili Interactive, a prescription digital medicine company developing treatments for cognitive dysfunction, closed a $55 million Series C financing round led by Temasek. Other participating institutional and strategic investors included Baillie Gifford, Amgen Ventures, M Ventures (the CVC fund of Merck KGaA, Darmstadt, Germany), JAZZ
Atomwise, Inc., today announced it has raised $45 million in growth funding, led by Monsanto Growth Ventures, DCVC (Data Collective), and B Capital Group. Prior investors Y Combinator, Khosla Ventures, and DFJ also participated in the financing, along with new investors Baidu Ventures, Tencent, and
Cota Inc., a healthcare evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (NYSE: IQV), with major participation by EW Healthcare Partners. Memorial Sloan Kettering Cancer Center also participated
SOPHiA GENETICS today announced the close of a $30-million Series D funding round. The round was led by London-based Balderton Capital, joined by 360º Capital Partners, alongside existing investors British tech star Mike Lynch's Invoke Capital and Alychlo, Belgian pharmaceutical entrepreneur Marc Coucke’s investment firm. The